Home » Topics » Regulatory

Regulatory
RSS

Restasis receives FDA approval

Jan. 7, 2003

Topamax sNDA submitted for migraine prevention

Jan. 7, 2003

Zindaclin receives further E.U. approvals

Jan. 7, 2003

Humira approved by FDA for RA

Jan. 3, 2003

Foradil Certihaler filed for approval in the U.S.

Jan. 3, 2003

Novartis files supplemental NDA for Starlix

Jan. 3, 2003

Olux approved for treatment of psoriasis

Jan. 3, 2003

Cephalon files sNDA for Provigil

Jan. 3, 2003

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Jan. 2, 2003